Overview

An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this multicenter, open-label, prospective study is to evaluate the effectiveness and safety of etanercept in the treatment of subjects with psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept